OHYAMA Naoki | Toxicology Laboratory, Pharmaceuticals Research Unit, Research & Development Division, Mitsubishi Ph
スポンサーリンク
概要
- 同名の論文著者
- Toxicology Laboratory, Pharmaceuticals Research Unit, Research & Development Division, Mitsubishi Phの論文著者
関連著者
-
MUTAI Mamoru
Toxicology Laboratory, Life Science Research Sector, Mitsubishi Chemical Co. Yokohama Research Cente
-
Mutai Mamoru
Toxicol.lab.life Sci.res.sect.mitsubishi Chemical Co. Ltd.
-
OHYAMA Naoki
Toxicology Laboratory, Pharmaceuticals Research Unit, Research & Development Division, Mitsubishi Ph
-
Ohyama Naoki
Toxicology Laboratory Mitsubishi Pharma Corporation
-
SUGIMOTO Jiro
Toxicology Lab., Mitsubishi Pharm.
-
Mutai M
Safety Research Laboratory (kazusa) Mitsubishi Tanabe Pharma Corporation
-
Mutai Mamoru
First Department Of Pathology Nagoya City University Medical School
-
Sugimoto Jiro
Safety Research Laboratory (kazusa) Mitsubishi Tanabe Pharma Corporation
-
Sugimoto Jirou
Toxicology Laboratory Pharmaceuticals Research Unit Research & Development Division Mitsubishi P
-
Ishii Shun-ichiro
Safety Research Laboratory (Kazusa), Mitsubishi Tanabe Pharma Corporation
-
Okada Miyoko
Safety Research Laboratory (Kazusa), Mitsubishi Tanabe Pharma Corporation
-
ISHII Shun-ichiro
Toxicology Laboratory, Pharmaceuticals Research Unit, Research & Development Division, Mitsubishi Ph
-
Sugimoto Jiro
Toxicology Laboratory Pharmaceuticals Research Unit Research & Development Division Mitsubishi P
-
Okada Miyako
Safety Research Laboratory (kazusa) Mitsubishi Tanabe Pharma Corporation
-
Okada Miyoko
Mitsubishi-tokyo Pharmaceuticals Incorporation Yokohama Research Center Pharmacokinetics And Toxicol
-
Mutai Mamoru
Safety Research Laboratory (kazusa) Mitsubishi Tanabe Pharma Corporation
-
Ohyama Naoki
Toxicology Laboratory Pharmaceuticals Research Unit Research & Development Division Mitsubishi P
-
Ishii Shun-ichiro
Safety Research Laboratory (kazusa) Mitsubishi Tanabe Pharma Corporation
-
Inoue Yoshimi
Fac. Of Pharmaceutical Sciences Toho Univ.
-
Inoue Yoshimi
Toxicology Laboratory Research And Development Division Mitsubishi Pharma Corporation
-
Mutai Mamoru
Toxicology Laboratory Yokohama Research Center Mitsubishi Chemical Corporation.
-
SHIBATA Hiroshi
Toxicology Laboratory, Pharmaceuticals Research Unit, Research & Development Division, Mitsubishi Ph
-
OKADA Miyoko
Toxicology Laboratory, Pharmaceuticals Research Unit, Research & Development Division, Mitsubishi Ph
-
Shibata Hiroshi
Toxicology Laboratory Pharmaceuticals Research Unit Research & Development Division Mitsubishi P
-
Mutai M
Toxicology Laboratory Pharmaceuticals Research Unit Research & Development Division Mitsubishi P
-
Mutai M
Toxicology Laboratory Pharmaceuticals Research Division Mitsubishi Pharma Corporation
-
SHINTAKU Yoshihisa
Toxicology Laboratory, Pharmaceuticals Research Unit, Research & Development Division, Mitsubishi Ph
-
SUGIYAMA Akio
Toxicology Laboratory, Pharmaceuticals Research Unit, Research & Development Division, Mitsubishi Ph
-
Sugiyama Akio
Toxicology Laboratory Pharmaceuticals Research Unit Research & Development Division Mitsubishi P
-
Shintaku Yoshihisa
Toxicology Laboratory Pharmaceuticals Research Unit Research & Development Division Mitsubishi P
-
Mori Mie
Toxicology Laboratory Pharmaceuticals Research Unit Research & Development Division Mitsubishi P
-
Mutai Mamoru
Toxicology Laboratory Mitsubishi Pharma Corporation
-
Mutai Mamoru
Toxicology Laboratory Mitsubishi-tokyo Pharmaceuticals Inc.
-
OKADA Miyako
Toxicology Laboratory, Pharmaceuticals Research Unit, Research & Development Division, Mitsubishi Ph
-
TSUTSUI Naohisa
Toxicology Laboratory, Research Center, Mitsubishi Pharma Corporation
-
Shimizu Toshinobu
Toxicology Laboratory, Pharmaceuticals Research Unit, Research & Development Division, Mitsubishi Ph
-
Masutomi Naoya
Toxicology Laboratory, Pharmaceuticals Research Unit, Research & Development Division, Mitsubishi Ph
-
Masutomi Naoya
Toxicology Laboratory Pharmaceuticals Research Unit Research & Development Division Mitsubishi P
-
Nakayama Kouji
Kashima Laboratory Mitsubishi Chemical Safety Institute Ltd.
-
Chen Genfu
In Vitro Technologies Inc.
-
SEKIJIMA Masaru
Kashima Laboratory, Mitsubishi Chemical Safety Institute LTD.
-
Tsutsui Naohisa
Toxicology Laboratory Mitsubishi Pharma Corporation
-
Kondo Hiroko
Pharmacokinetics Laboratory Mitsubishi Pharma Corporation
-
IWASE Yumiko
Toxicology Laboratory, Mitsubishi Pharma Corporation
-
KIFUJI Takayuki
Pharmacokinetics Laboratory, Mitsubishi Pharma Corporation
-
FUJISAKI Hiroshi
Quality Control Department, Mitsubishi Pharma Corporation
-
TAKAMATSU Yasuo
Pharmacokinetics Laboratory, Mitsubishi Pharma Corporation
-
SILBER Paul
In Vitro Technologies, Inc.
-
Silber Paul
In Vitro Technologies Inc.
-
Iwase Yumiko
Toxicology Laboratory Mitsubishi Pharma Corporation
-
Shimizu Toshinobu
Toxicogenomics Project National Institute Of Biomedical Innovation
-
Sekijima Masaru
Kashima Laboratory Mitsubishi Chemical Safety Institute Ltd.
-
Takamatsu Yasuo
Pharmacokinetics Laboratory Mitsubishi Pharma Corporation
-
Kifuji Takayuki
Pharmacokinetics Laboratory Mitsubishi Pharma Corporation
-
Fujisaki Hiroshi
Quality Control Department Mitsubishi Pharma Corporation
-
Shimizu Toshinobu
Toxicology Laboratory Pharmaceuticals Research Unit Research & Development Division Mitsubishi P
-
Masutomi Naoya
Toxicology Laboratory Pharmaceuticals Research Unit Research & Development Division Mitsubishi P
著作論文
- Effect of dosing interval between edaravone and cefalotin/glycerol on the nephrotoxicity in rats(Kidney, Urinary system, Proceedings of the 32nd Annual Meeting)
- P7-14 Renal Toxicity of Furosemide in Rats : Effects of Water-Deprived Condition or Coadministration of Cefalotin and Glycerol(IMMUNE AND ALLERGIC SYSTEM/KIDNEYS AND URINARY EXCRETION SYSTEM/CYTOTOXICITY/OTHERS-1)(GENERAL SESSION BY POSTER PRESENTATION)(P
- O-22 Nephrotoxic effect of edaravone in combination with cefalotin and glycerol in rats(KIDNEYS AND URINARY EXCRETION SYSTEM)(GENERAL SESSION BY ORAL PRESENTATION)(Proceedings of the 31st Annual Meeting)
- Gene expression profiling of rat kidneys following dose of edaravone in combination with cefalotin and glycerol(Kidney, Urinary system, Proceedings of the 32nd Annual Meeting)
- O-25 Cytotoxic effects of edaravone in human renal cells(KIDNEYS AND URINARY EXCRETION SYSTEM)(GENERAL SESSION BY ORAL PRESENTATION)(Proceedings of the 31st Annual Meeting)